Introduction to Clinical Pharmacology Chapter 34 Antihyperlipidemic Drugs.

Slides:



Advertisements
Similar presentations
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Advertisements

Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Agents Used in the Treatment of Hyperlipidemia
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs.
Lipids 101 Cardiology Board Review Med-Peds Style!
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 50 Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol.
ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.
Pharmacology of Agents Used in Hyperlipidemia
1 Drugs for Hyperlipidemia Lipids are necessary for human life Cholesterol –Essential component of cell membrane –Precursor to the sterol and steroid compounds.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Department of Family & Community Medicine
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
ANTIHYPERLIPIDEMIC DRUGS
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Antihyperlipidemia.
Cholesterol and Triglycerides. What are triglycerides? Type of lipid found in your blood Store unused calories in your fat cells Hormones release triglycerides.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
HYPERLIPIDEMIA Applied Therapeutics Dr. Riyadh Mustafa Al-Salih.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
Management of Hyperlipoprotinaemia
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Case 4 Chang Chia-Chieh(Tony). Mr. Reyes was prescribed Lovastatin 20mg. b.i.d. and told to return in 6 weeks.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
Drugs Used in Hyperlipidemia
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
LIPID-LOWERING DRUGS Dr. Arwa Mahmood Fuzi Alsarraf.
Antihyperlipidemic Drugs
Chapter 18 Drugs Used to Lower Lipids
أبدا لم يفت الاوان لكي تبدأ
Drugs for Lipid Disorders
Anti-Hypercholesterolemic Agents
By: Dr Israa Omar MBBS, MRCP, MSc pharmacology
Drugs for Hyperlipidemias
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
Antilipidaemic agents
Antihyperlipidemic Drugs
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Cardiovascular System
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 33 Diuretics
Lecture 5b 7 Feb 2011 Atherosclerosis-Nutritional intervention-
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
Review of Anatomy and Physiology
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Cholinesterase Inhibitors: Actions and Uses
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Presentation transcript:

Introduction to Clinical Pharmacology Chapter 34 Antihyperlipidemic Drugs

Lipoproteins Low-density lipoproteins (LDLs): Transport cholesterol to the peripheral cells Elevation of LDLs: Atherosclerotic plaque formation Increases the risk for heart disease High-density lipoproteins (HDLs): Take cholesterol from the peripheral cells and transport it to the liver

Cholesterol Levels HDL cholesterol: protects against heart disease The higher the LDL level, the greater the risk for heart disease Drugs used to treat hyperlipidemia: Bile acid resins HMG-CoA reductase inhibitors Fibric acid derivatives Niacin

HMG-CoA Reductase Inhibitors: Actions HMG-CoA reductase (aka the Statins): An enzyme that is a catalyst during the manufacture of cholesterol Inhibits the manufacture of cholesterol or promotes the breakdown of cholesterol Lowers the blood levels of cholesterol and serum triglycerides Increases blood levels of HDLs

HMG-CoA Reductase Inhibitors: Uses As adjunct to diet in the treatment of hyperlipidemia For primary prevention of coronary events in patients with hyperlipidemia without clinically evident coronary heart disease to reduce the risk of myocardial infarction and death from other cardiovascular events, including strokes, transient ischemic attacks, and cardiac revascularization procedures For secondary prevention of cardiovascular events in patients with hyperlipidemia with evident coronary heart disease

HMG-CoA Reductase Inhibitors: Adverse Reactions Central nervous system reactions: headache, dizziness, insomnia, memory and cognitive impairment Gastrointestinal reactions: flatulence, abdominal pain, cramping, constipation, nausea, hyperglycemia in nondiabetic patients Other: elevated CPK level, rhabdomyolysis with possible renal failure

HMG-CoA Reductase Inhibitors: Contraindications and Precautions Contraindicated in patients: with hypersensitivity to the drugs, serious liver disorders During pregnancy and lactation In some individuals with diabetes risk factors, statin drugs may elevate serum glucose and HbA1c levels. Used cautiously in patients with: History of alcoholism, non-alcohol-related liver disease, acute infection, hypotension, trauma, endocrine disorders, visual disturbances, and myopathy

HMG-CoA Reductase Inhibitors: Interactions #1 Interactant drug Effect of interaction Macrolides, erythromycin, clarithromycin Increased risk of severe myopathy or rhabdomyolysis Amiodarone Increased risk for myopathy and for severe myopathy or rhabdomyolysis Niacin Increased risk for severe myopathy or rhabdomyolysis

HMG-CoA Reductase Inhibitors: Interactions #2 Interactant drug Effect of interaction Protease inhibitors Elevated plasma levels of HMG-CoA reductase inhibitors Verapamil Increased risk for myopathy Warfarin Increased anticoagulant effect

Bile Acid Resins: Actions and Uses Bile: manufactured, secreted by liver; stored in the gallbladder; emulsifies fat, lipids Increased loss of bile acids: Liver uses cholesterol to manufacture more bile Used to treat hyperlipidemia; pruritus associated with partial biliary obstruction, gallstone dissolution

Bile Acid Resins: Adverse Reactions Constipation Aggravation of hemorrhoids Abdominal cramps Flatulence Nausea Increased bleeding tendencies related to vitamin K malabsorption, and vitamin A and D deficiencies

Bile Acid Resins: Contraindications and Precautions Contraindicated in patients: With known hypersensitivity to the drugs With complete biliary obstruction Used cautiously in patients: With diabetes, liver disease, kidney disease, peptic ulcer During pregnancy and lactation

Bile Acid Resins: Interactions #1 Interactant drug Effect of interaction Anticoagulants Decreased effect of the anticoagulant (cholestyramine) Thyroid hormone Loss of efficacy of thyroid; also hypothyroidism (particularly with cholestyramine) fat-soluble vitamins (A, D, E, K) and folic acid Reduced absorption of vitamins

Bile Acid Resins : Interactions #2 Interactant drug Effect of interaction NSAIDS, penicillin G, tetracycline, glipizide, niacin, digitalis glycosides Decreased serum level or decreased GI absorption Furosemide, thiazide diuretics, hydrocortisone, methyldopa, propranolol

Fibric Acid Derivatives: Actions #1 Fenofibrate: Reduces VeryLowDensityLipoproteins Stimulates catabolism of triglyceride-rich lipoproteins Decreases plasma triglycerides, cholesterol

Fibric Acid Derivatives: Actions #2 Gemfibrozil: Increases excretion of cholesterol in the feces Reduces the production of triglycerides by the liver Lowers serum lipid levels

Fibric Acid Derivatives: Uses Gemfibrozil: Used to treat individuals with very high serum triglyceride levels who are at risk for abdominal pain, pancreatitis Fenofibrate: Used as adjunctive treatment for reducing LDLs, total cholesterol, triglycerides in patients with hyperlipidemia

Fibric Acid Derivatives Adverse reactions: Nausea, vomiting, GI upset, diarrhea, cholelithiasis or cholecystitis Contraindicated in patients: With hypersensitivity to the drugs and those with significant hepatic or renal dysfunction or primary biliary cirrhosis Used cautiously in patients: With peptic ulcer disease, diabetes; during pregnancy and lactation

Fibric Acid Derivatives: Interactions #1 Interactant drug Effect of interaction Anticoagulants Enhanced effects of the anticoagulants (particularly with gemfibrozil and fenofibrate) Cyclosporine Decreased effects of cyclosporine (particularly with gemfibrozil)

Fibric Acid Derivatives: Interactions #2 Interactant drug Effect of interaction HMG-CoA (Statins) Increased risk for rhabdomyolysis (particularly with gemfibrozil and fenofibrate) Sulfonylureas Increased hypoglycemic effects (particularly with gemfibrozil)

Miscellaneous Antihyperlipidemic Drugs: Niacin and Ezetimibe Action: lowers blood lipid levels Uses: adjunctive therapy for lowering very high serum triglyceride levels in patients who are at risk for pancreatitis Adverse reactions: Gastrointestinal reactions: nausea, vomiting, abdominal pain, diarrhea Other reactions: severe generalized flushing of the skin, sensation of warmth, severe itching or tingling

Miscellaneous Antihyperlipidemic Drugs: Contraindications and Precautions Contraindicated in patients: With known hypersensitivity to niacin, active peptic ulcer, hepatic dysfunction, and arterial bleeding Used cautiously in patients with: Renal dysfunction, high alcohol consumption, unstable angina, gout, pregnancy

Nursing Process: Assessment Preadministration assessment: Take a dietary history; record vital signs and weight; inspect skin and eyelids for evidence of xanthomas Ongoing assessment: Monitor liver function tests, such as serum transaminase levels Frequently monitor blood cholesterol and triglyceride levels Periodic lipid profiles

Nursing Process: Diagnoses Constipation related to antihyperlipidemic drugs Risk for Imbalanced Nutrition: Less Than Body Requirements related to malabsorption of vitamins Risk for Impaired Skin Integrity related to rash and flushing Nausea related to antihyperlipidemic drugs Risk for Injury related to dizziness

Nursing Process: Planning Expected outcome: Optimal response to therapy Management of common adverse drug reactions Understanding of the dietary measures necessary to reduce lipid and lipoprotein levels

Nursing Process: Implementation #1 Promoting an optimal response to therapy: Explain drug regimen and possible adverse reactions Emphasize the importance of following printed dietary guidelines

Nursing Process: Implementation #2 Monitoring and managing patient needs: Constipation: increase fluid intake, eat foods high in dietary fiber, exercise daily Risk for imbalanced nutrition: less than body requirements Bile acid resins used for long-term therapy: administer vitamins A, D in water-soluble form or parenterally

Nursing Process: Implementation #3 Monitoring and managing patient needs (cont.) Risk for impaired skin integrity: contact health care provider Nausea: take drug with meal; provide patient with several small meals rather than three large meals Risk for injury: place the call light within easy reach

Nursing Process: Implementation #4 Monitoring and managing patient needs (cont.) Potential complication: Vitamin K deficiency: include foods high in vitamin K in the patient’s diet Rhabdomyolysis: be alert for unexplained muscle pain, muscle tenderness, or weakness, especially if accompanied by malaise or fever

Nursing Process: Implementation #5 Educating the patient and family: Usually statins are taken in the evening or at bedtime. Choose juices other than grapefruit juice because of an enzyme reaction. Antacids should be taken at least 2 hours after rosuvastatin These drugs may cause photosensitivity; avoid exposure to the sun and wear both sunscreen and protective clothing Advise the patient to contact the primary health care provider as soon as possible if muscle pain, tenderness, or weakness occurs.

Nursing Process: Evaluation #1 Therapeutic effect is achieved; serum lipid levels are decreased Adverse reactions are identified, reported, and managed successfully Improved bowel movements Nutritional vitamin needs will be met

Nursing Process: Evaluation #2 Skin will remain intact Nausea is controlled The patient reports no injury related to dizziness or falls The patient and family demonstrate understanding of the treatment regimen

Question #1 Is the following statement true or false? Atherosclerosis is a disorder in which lipid deposits accumulate on the lining of blood vessels.

Answer to Question #1 True Atherosclerosis is a disorder in which lipid deposits accumulate on the lining of blood vessels.

Question #2 Is the following statement true or false? Cholesterol and triglycerides are two lipids in our blood; elevation of one or both is termed hyperlipidemia.

Answer to Question #2 True Cholesterol and triglycerides are two lipids in our blood; elevation of one or both is termed hyperlipidemia.

Question #3 Is the following statement true or false? Bile acid resins are frequently called “statin” drugs. These drugs lower the blood level of cholesterol low- density lipoproteins (LDLs) and triglycerides.

Answer to Question #3 False HMG-CoA reductase inhibitors are frequently called “statin” drugs. These drugs lower the blood level of cholesterol low-density lipoproteins (LDLs) and triglycerides. Bile acid resins and fibric acid derivatives act in a similar manner to reduce cholesterol by binding with bile so the liver will use more, putting less in the system.